<?xml version="1.0" encoding="utf-8" ?>
<rss version="2.0" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Cision Wire</title>
    <link>http://www.cisionwire.com</link>
    <description>Cision is the leading global provider of media research, distribution, monitoring and evaluation services. With over 40 locations throughout the world, Cision provides the insight, expertise and intelligence that improve performance and build reputations.</description>
    <pubDate>Fri, 10 Feb 2012 02:34:22 GMT</pubDate>
    <image>
      <title>Cision Wire</title>
      <width>120</width>
      <height>32</height>
      <link>http://www.cisionwire.com</link>
      <url>http://www.cisionwire.com/images/CisionLogoSmall.gif</url>
    </image>
    <item>
      <title>Biotage is subject to extended patent litigation in the US</title>
      <link>http://www.cisionwire.com/biotage/r/biotage-is-subject-to-extended-patent-litigation-in-the-us,c9206314</link>
      <guid isPermaLink="false">cision438271</guid>
      <description><![CDATA[<p><strong></strong></p>]]></description>
      <pubDate>Thu, 12 Jan 2012 07:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Changes in Management of Biotage AB</title>
      <link>http://www.cisionwire.com/biotage/r/changes-in-management-of-biotage-ab,c9178578</link>
      <guid isPermaLink="false">cision409592</guid>
      <description><![CDATA[]]></description>
      <pubDate>Wed, 26 Oct 2011 06:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Biotage AB Nomination Committee</title>
      <link>http://www.cisionwire.com/biotage/r/biotage-ab-nomination-committee,c9178557</link>
      <guid isPermaLink="false">cision409597</guid>
      <description><![CDATA[]]></description>
      <pubDate>Wed, 26 Oct 2011 06:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Following Biotage’s request for re-examination US Patent and Trademark Office has rejected all claims in US patent 7,410,571</title>
      <link>http://www.cisionwire.com/biotage/r/following-biotage-s-request-for-re-examination-us-patent-and-trademark-office-has-rejected-all-claim,c9159452</link>
      <guid isPermaLink="false">cision390481</guid>
      <description><![CDATA[<p><strong></strong></p>]]></description>
      <pubDate>Thu, 08 Sep 2011 07:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Following Biotage’s request for re-examination US Patent and Trademark Office has rejected all claims in US patent 7,138,061</title>
      <link>http://www.cisionwire.com/biotage/r/following-biotage-s-request-for-re-examination-us-patent-and-trademark-office-has-rejected-all-claims-in-us-patent-7-138-061,c9119371</link>
      <guid isPermaLink="false">cision343110</guid>
      <description><![CDATA[]]></description>
      <pubDate>Mon, 09 May 2011 12:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Biotage AB launches share buy-back</title>
      <link>http://www.cisionwire.com/biotage/r/biotage-ab-launches-share-buy-back,c569856</link>
      <guid isPermaLink="false">cision341266</guid>
      <description><![CDATA[<p><strong>The board of directors of Biotage AB (publ) has resolved to start a share buy-back program in accordance with the Annual General Meeting&rsquo;s resolution to authorize the board to decide on the acquisition and sale of the company&rsquo;s own shares.</strong></p>]]></description>
      <pubDate>Fri, 06 May 2011 06:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Resolutions at the Annual General Meeting in Biotage AB on April 27, 2011</title>
      <link>http://www.cisionwire.com/biotage/r/resolutions-at-the-annual-general-meeting-in-biotage-ab-on-april-27--2011,c566488</link>
      <guid isPermaLink="false">cision312504</guid>
      <description><![CDATA[<p><strong> </strong></p>]]></description>
      <pubDate>Wed, 27 Apr 2011 15:30:00 GMT</pubDate>
    </item>
    <item>
      <title>Biotage AB (publ) publishes its 2010 Annual Report</title>
      <link>http://www.cisionwire.com/biotage/r/biotage-ab--publ--publishes-its-2010-annual-report,c560653</link>
      <guid isPermaLink="false">cision308398</guid>
      <description><![CDATA[]]></description>
      <pubDate>Wed, 06 Apr 2011 06:30:00 GMT</pubDate>
    </item>
    <item>
      <title>NOTICE OF ANNUAL GENERAL MEETING IN BIOTAGE AB (publ)</title>
      <link>http://www.cisionwire.com/biotage/r/notice-of-annual-general-meeting-in-biotage-ab--publ-,c559272</link>
      <guid isPermaLink="false">cision307526</guid>
      <description><![CDATA[]]></description>
      <pubDate>Fri, 25 Mar 2011 08:00:00 GMT</pubDate>
    </item>
    <item>
      <title>Following Biotage’s request for re-examination US Patent and Trademark Office has rejected all claims in US patent 7,381,327</title>
      <link>http://www.cisionwire.com/biotage/r/following-biotage-s-request-for-re-examination-us-patent-and-trademark-office-has-rejected-all-claims-in-us-patent-7-381-327,c554827</link>
      <guid isPermaLink="false">cision304410</guid>
      <description><![CDATA[]]></description>
      <pubDate>Wed, 16 Mar 2011 12:00:00 GMT</pubDate>
    </item>
  </channel>
</rss>
